Hematology Archives - Page 5 of 5

Cost-utility of Elbasvir/Grazoprevir in patients with chronic hepatitis C genotype 1 infection

Authors: S Corman, E H Elbasha, S N Michalopoulos, C Nwankwo Published: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2017 View publication Objective To...

Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: a Germany and United Kingdom retrospective study

Authors: P J Brockelmann, E A Zagadailov, S L Corman, V Chirikov, C Johnson, C Macahilig, B Seal, M R Dalal, T Illidge Published: European Journal of Haematology, 2017 View publication Objective...

Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy

Authors: E G Horodniceanu, V Bal, H Dhatt, J A Carter, V Huang, K Lasch Published: Health and quality of life outcomes, 2017 View publication Background Compliance, palatability, gastrointestinal (GI) symptom, and...

Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands

Authors: M Heisen, M J Treur, H E Heemstra, E B W Giesen, M J Postma Published: Journal of medical economics, 2017 View publication Background Until recently, standard treatment of venous thromboembolism...

News